As our understanding of genomics grows, we are beginning to see the role our genetic makeup plays in our general health. In this podcast, Dr. Paul Anderson answers the following questions: How does our emerging understanding of genetics and health affect our choices of treatment, diet and lifestyle? How can modern testing help guide prevention strategies?
In our healthcare system today, the physician’s time is essentially rationed. This happens in two way -healthcare provider organizations strictly limit the amount of time a physician can spend with any one patient. And insurance restrict access to physicians (and the procedures they might perform) through plan rules and processes. This is the inevitable result of an increasing volume of patients trying to gain access to a pool of physicians that is growing a very modest rate. In this podcast, we explore the ways that the healthcare system is adjusting to this reality and the consequences for patients and the quality of care they receive.
What can we tell from modern genetic testing, and how can this new information help both in the prevention and treatment of common health concerns? In this podcast, Dr. Paul Anderson these questions and gives an overview of clinical genomics.
In this podcast, we explore the question: Could a physician really be replaced by a computer? Technology is making this more possible in the area of medical diagnostics. And there are several compelling reasons why we may prefer an “”artificial” physician to the human equivalent.
Personal genome sequencing costs have fallen sharply over the last several years, and more individuals are taking advantage of genetic testing services to learn about their ancestry and what diseases they might be susceptible to. There are privacy risks, however, that consumers often ignore when sharing their genetic data with these services.
During the last several years, dozens of patients have been infected by improperly sterilized endoscopes, known as duodenoscopes. The FDA has cited the manufacturers of these devices for violations ranging from not properly evaluating cleaning, sterilization and testing procedures to failure to report infections and other problems. Despite the fact that 13 patients have died from these infections, the agency has decided to leave the devices on the market because of their value in life-saving procedures.